The gut microbiota in inflammatory bowel disease
- PMID: 19442170
- DOI: 10.2174/138161209788168146
The gut microbiota in inflammatory bowel disease
Abstract
Crohn's disease and ulcerative colitis are the two principal forms of inflammatory bowel disease (IBD). The root causes of these chronic and acute immunological disorders are unclear, but intestinal microorganisms are known to play a key role in the initiation and maintenance of disease. However, at present, there is no clear evidence for a single transmissible agent being involved in IBD aetiology. Although marked alterations occur in faecal and mucosal bacterial communities in IBD, it is unclear whether they are responsible for causing disease, or are due to changes in the gut environment that result from inflammatory reactions and extensive tissue destruction. Despite the involvement of microorganisms in inflammatory processes, antibiotic therapy has generally been unsuccessful in IBD. However, recent studies involving the use of probiotics, prebiotics and synbiotics suggest that there is potential for controlling these diseases through manipulation of the composition of the gut microbiota, and direct interactions with the gut immune system.
Similar articles
-
Probiotics and prebiotics in Crohn's disease therapies.Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):81-8. doi: 10.1016/j.bpg.2016.02.002. Epub 2016 Feb 9. Best Pract Res Clin Gastroenterol. 2016. PMID: 27048899 Review.
-
Microbiota and mucosal defense in IBD: an update.Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):963-976. doi: 10.1080/17474124.2019.1671822. Epub 2019 Oct 11. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31603356 Review.
-
Review of Saccharomyces boulardii as a treatment option in IBD.Immunopharmacol Immunotoxicol. 2018 Dec;40(6):465-475. doi: 10.1080/08923973.2018.1469143. Epub 2018 May 17. Immunopharmacol Immunotoxicol. 2018. PMID: 29771163 Review.
-
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.Postgrad Med. 2014 Jul;126(4):7-19. doi: 10.3810/pgm.2014.07.2779. Postgrad Med. 2014. PMID: 25141239 Review.
-
Role of antibiotics for treatment of inflammatory bowel disease.World J Gastroenterol. 2016 Jan 21;22(3):1078-87. doi: 10.3748/wjg.v22.i3.1078. World J Gastroenterol. 2016. PMID: 26811648 Free PMC article. Review.
Cited by
-
Cyclic-di-AMP confers an invasive phenotype on Escherichia coli through elongation of flagellin filaments.Gut Pathog. 2024 Jan 24;16(1):6. doi: 10.1186/s13099-024-00600-4. Gut Pathog. 2024. PMID: 38267967 Free PMC article.
-
Biofilm's Impact on Inflammatory Bowel Diseases.Cureus. 2023 Sep 18;15(9):e45510. doi: 10.7759/cureus.45510. eCollection 2023 Sep. Cureus. 2023. PMID: 37868553 Free PMC article. Review.
-
The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease.Front Microbiol. 2023 Jun 14;14:1188455. doi: 10.3389/fmicb.2023.1188455. eCollection 2023. Front Microbiol. 2023. PMID: 37389342 Free PMC article. Review.
-
Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance.Front Immunol. 2021 Apr 29;12:669672. doi: 10.3389/fimmu.2021.669672. eCollection 2021. Front Immunol. 2021. PMID: 33995404 Free PMC article.
-
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.Front Microbiol. 2021 Mar 23;12:639948. doi: 10.3389/fmicb.2021.639948. eCollection 2021. Front Microbiol. 2021. PMID: 33833742 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical